Primary Care Provider Guide to Neonatal Abstinence Syndrome Follow Up
Primary Care Provider Guide to Neonatal Abstinence Syndrome Follow Up https://pediatricsnationwide.org/wp-content/themes/corpus/images/empty/thumbnail.jpg 150 150 Nationwide Children's https://secure.gravatar.com/avatar/8087ae3f73e51e24df5819a3363b55e0?s=96&d=mm&r=gPediatricians have a unique challenge when it comes to caring for the broad spectrum of needs associated with opioid-exposed infants. Some babies who were treated with pharmacological methods in a hospital will be discharged home still on neuro-active medications. Other babies did not receive a neonatal abstinence syndrome (NAS) diagnosis or specific treatment after birth but are at high risk and may show signs of developmental problems. Nathalie Maitre, MD, PhD, director of the NICU Follow-up Program at Nationwide Children’s Hospital, and her team have developed two key algorithms to support the care of opioid-exposed infants.
